Latest CAXTON CORP Stock Portfolio
CAXTON CORP Performance:
2024 Q3: 19.15%YTD: 45.83%2023: 67.85%
Performance for 2024 Q3 is 19.15%, and YTD is 45.83%, and 2023 is 67.85%.
About CAXTON CORP and 13F Hedge Fund Stock Holdings
In it's latest 13F Holdings report, CAXTON CORP reported an equity portfolio of $24.2 Millions as of 30 Sep, 2024.
The top stock holdings of CAXTON CORP are XERS, RZLT, SPY. The fund has invested 60.3% of it's portfolio in XERIS BIOPHARMA HOLDINGS INC and 26.5% of portfolio in REZOLUTE INC.
The fund managers got completely rid off MOLECULAR TEMPLATES INC (MTEM) stocks. They significantly reduced their stock positions in ABIVAX SA. CAXTON CORP opened new stock positions in BICARA THERAPEUTICS INC. The fund showed a lot of confidence in some stocks as they added substantially to SPDR S&P 500 ETF TR (SPY), BERKSHIRE HATHAWAY INC DEL and MIND MEDICINE MINDMED INC (MNMD).
The top stock holdings of CAXTON CORP are XERS, RZLT, SPY. The fund has invested 60.3% of it's portfolio in XERIS BIOPHARMA HOLDINGS INC and 26.5% of portfolio in REZOLUTE INC.
The fund managers got completely rid off MOLECULAR TEMPLATES INC (MTEM) stocks. They significantly reduced their stock positions in ABIVAX SA. CAXTON CORP opened new stock positions in BICARA THERAPEUTICS INC. The fund showed a lot of confidence in some stocks as they added substantially to SPDR S&P 500 ETF TR (SPY), BERKSHIRE HATHAWAY INC DEL and MIND MEDICINE MINDMED INC (MNMD).
CAXTON CORP Annual Return Estimates Vs S&P 500
Our best estimate is that CAXTON CORP made a return of 19.15% in the last quarter. In trailing 12 months, it's portfolio return was 58.61%.
New Buys
| Ticker | $ Bought |
|---|---|
| bicara therapeutics inc | 278,669 |
New stocks bought by CAXTON CORP
Additions
| Ticker | % Inc. |
|---|---|
| spdr s&p 500 etf tr | 53.4 |
| berkshire hathaway inc del | 12.29 |
| mind medicine mindmed inc | 12.14 |
Additions to existing portfolio by CAXTON CORP
Reductions
| Ticker | % Reduced |
|---|---|
| abivax sa | -18.24 |
CAXTON CORP reduced stake in above stock
Sold off
| Ticker | $ Sold |
|---|---|
| molecular templates inc | -157,396 |
CAXTON CORP got rid off the above stocks
Sector Distribution
CAXTON CORP has about 88.2% of it's holdings in Healthcare sector.
| Sector | % |
|---|---|
| Healthcare | 88.2 |
| Others | 11.8 |
Market Cap. Distribution
CAXTON CORP has about 0% of it's portfolio invested in the large-cap and mega-cap stocks.
| Category | % |
|---|---|
| SMALL-CAP | 61.1 |
| MICRO-CAP | 27.1 |
| UNALLOCATED | 11.8 |
Stocks belong to which Index?
About 60.7% of the stocks held by CAXTON CORP either belong to S&P 500 or RUSSELL 2000 index.
| Index | % |
|---|---|
| RUSSELL 2000 | 60.7 |
| Others | 39.3 |
CAXTON CORP Holdings Map
This heatmap illustrates the top 50 positions within the fund's portfolio.
Current Stock Holdings of CAXTON CORP
CAXTON CORP has 12 stocks in it's portfolio. MNMD proved to be the most loss making stock for the portfolio. XERS was the most profitable stock for CAXTON CORP last quarter.
Last Reported on: 14 Nov, 2024| Ticker | Namesorted ascending | % Portfolio | Shares Held | $ Value | Type | % Change | Options | |
|---|---|---|---|---|---|---|---|---|
| ACET | adicet bio inc | 0.10 | 17,488 | 25,182 | unchanged | 0.00 | ||
| CMPX | compass therapeutics inc | 0.33 | 43,465 | 79,976 | unchanged | 0.00 | ||
| CNTX | context therapeutics inc | 0.15 | 18,403 | 36,071 | unchanged | 0.00 | ||
| MNMD | mind medicine mindmed inc | 0.80 | 34,073 | 193,876 | added | 12.14 | ||
| MTEM | molecular templates inc | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| RZLT | rezolute inc | 26.47 | 1,318,970 | 6,396,990 | unchanged | 0.00 | ||
| SPY | spdr s&p 500 etf tr | 6.81 | 2,867 | 1,644,910 | added | 53.4 | ||
| XERS | xeris biopharma holdings inc | 60.31 | 5,113,350 | 14,573,000 | unchanged | 0.00 | ||
| berkshire hathaway inc del | 2.19 | 1,151 | 529,573 | added | 12.29 | |||
| bicara therapeutics inc | 1.15 | 10,941 | 278,669 | new | ||||
| lexeo therapeutics inc | 0.67 | 17,851 | 161,374 | unchanged | 0.00 | |||
| abivax sa | 0.54 | 11,365 | 130,925 | reduced | -18.24 | |||
| kyverna therapeutics inc | 0.47 | 22,981 | 112,378 | unchanged | 0.00 | |||